470 related articles for article (PubMed ID: 37496657)
1. The role of cancer-associated fibroblasts in breast cancer metastasis.
Li Y; Wang C; Huang T; Yu X; Tian B
Front Oncol; 2023; 13():1194835. PubMed ID: 37496657
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
3. The role of cancer-associated fibroblasts in breast cancer pathobiology.
Jung YY; Kim HM; Koo JS
Histol Histopathol; 2016 Apr; 31(4):371-8. PubMed ID: 26627101
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers.
Wright K; Ly T; Kriet M; Czirok A; Thomas SM
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980785
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
8. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.
Koontongkaew S
J Cancer; 2013; 4(1):66-83. PubMed ID: 23386906
[TBL] [Abstract][Full Text] [Related]
9. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications.
Qiao A; Gu F; Guo X; Zhang X; Fu L
Front Med; 2016 Mar; 10(1):33-40. PubMed ID: 26791754
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic therapy to normalize the tumor microenvironment.
Hauge A; Rofstad EK
J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
[TBL] [Abstract][Full Text] [Related]
13. Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.
Folgueira MA; Maistro S; Katayama ML; Roela RA; Mundim FG; Nanogaki S; de Bock GH; Brentani MM
Biosci Rep; 2013 Dec; 33(6):. PubMed ID: 24229053
[TBL] [Abstract][Full Text] [Related]
14. Heterocellular Adhesion in Cancer Invasion and Metastasis: Interactions between Cancer Cells and Cancer-Associated Fibroblasts.
Yamaguchi H; Miyazaki M
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730588
[TBL] [Abstract][Full Text] [Related]
15. Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression.
Dhungel N; Dragoi AM
Front Mol Biosci; 2024; 11():1379971. PubMed ID: 38863965
[TBL] [Abstract][Full Text] [Related]
16. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors.
He C; Wang L; Li L; Zhu G
Transl Oncol; 2021 Dec; 14(12):101231. PubMed ID: 34601397
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
Ai W; Liu T; Lv C; Feng X; Wang Q
Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
[TBL] [Abstract][Full Text] [Related]
19. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.
Zhang J; Gu C; Song Q; Zhu M; Xu Y; Xiao M; Zheng W
Cell Biosci; 2020 Oct; 10(1):127. PubMed ID: 33292459
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
